Thursday, 10 November 2016

Cosmo shares jump on colonoscopy trial results

ZURICH (Reuters) - Shares in Swiss-listed drugmaker Cosmo Pharmaceuticals jumped more than 10 percent on Thursday after it reported its dye tablets helped doctors detect intestinal growths during colonoscopies.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)